USD/KRW Tests Key Support Levels After Failing to Surpass June High

Neutral (-0.2)Impact: Medium

Published on July 21, 2026 (3 hours ago) · By Vibe Trader

USD/KRW Tests Key Support Levels After Failing to Surpass June High

Societe Generale’s technical team reports that the USD/KRW currency pair failed twice to break above the June high near 1,561, which has led to a deeper decline towards the 200-day moving average (200-DMA) [1]. The pair is currently testing this key technical level, which previously acted as support during pullbacks in February and May [1].

The next significant support is identified at a multi-month ascending trend line near 1,464/1,461 [1]. According to Societe Generale, reaching this support zone could trigger a rebound in USD/KRW; however, any upward movement may be limited by the recent pivot high at 1,491 [1]. If the pair fails to break above 1,491, downside risks remain, potentially leading to an extended decline [1].

No specific market reactions, analyst opinions beyond the technical outlook, or forward-looking statements regarding broader market implications are provided in the source [1].

CONCLUSION

USD/KRW is currently at a critical technical juncture, with support at 1,464/1,461 and resistance at 1,491. The inability to break above resistance could keep downside risks in play, according to Societe Generale. Market participants are likely to watch these levels closely for further direction.

Turn today's news into tomorrow's trade.

Try Vibe Trader Free →

Feel free to email us at team@vibetrader@gmail.com

Was this page helpful?

Related Articles

Super Micro Computer Soars 15% on $60 Billion in New Orders and Margin Upgrade Following SpaceX Collaboration

Super Micro Computer shares surged 15% after the company announced it received m...

Read full article

OpenAI Adds Financial Leaders to Board Amid IPO Preparations

OpenAI announced the appointment of David Vélez, CEO of Nubank, and Robin Vince,...

Read full article

Novo Nordisk Sues Eli Lilly Over Allegedly Misleading Weight-Loss Drug Advertisements

Novo Nordisk has filed a lawsuit against Eli Lilly in federal court in New Jerse...

Read full article